Braxia Scientific Corp.
BRAXF · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2 | $4 | $6 | $7 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | $2 | $3 | $5 | $6 |
| Revenue | $0 | $1 | $1 | $1 |
| % Growth | -17.1% | -1% | 14.9% | – |
| Gross Profit | $0 | $0 | -$0 | -$1 |
| % Margin | 16.6% | 0.8% | -22.2% | -192.4% |
| EBITDA | -$1 | -$0 | -$1 | -$2 |
| % Margin | -164% | -29.2% | -123.6% | -407.1% |
| Net Income | -$1 | -$0 | -$1 | -$8 |
| % Margin | -184.2% | -45.9% | -133.7% | -1,465.8% |
| EPS Diluted | -0.003 | -0.001 | -0.003 | -0.029 |
| % Growth | -240% | 66.7% | 89.7% | – |
| Operating Cash Flow | -$1 | -$0 | -$1 | -$1 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$0 | -$1 | -$1 |